Non-small Cell Carcinoma Biomarker Testing: The Cytopathologist’s Viewpoint
Abberly Lott Limbach, MD
Many decisions about treatment in lung cancer are made on the basis of specific molecular and protein expression. This webinar is designed to give practicing cytopathologists a general introduction to the targeted therapy testing required for non-small cell lung carcinomas as well as a strategy to maximize limited specimens for several rounds of testing. In this course we will review the pre-analytical factors in specimen collection, from EBUS to biopsy to resection, and consider how specimen collection can affect testing. Finally, we will discuss several case examples alongside the targeted therapy testing followup and consider how to integrate targeted therapy testing into the cytopathologist’s immediate assessment workflow.
|Earn 2 credits per webinar|